πŸ‡ΊπŸ‡Έ FDA
Patent

US 11261151

Methods for making and using endoxifen

granted A61KA61K45/06A61K9/0053

Quick answer

US patent 11261151 (Methods for making and using endoxifen) held by ATOSSA THERAPEUTICS, INC. expires Mon Feb 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ATOSSA THERAPEUTICS, INC.
Grant date
Tue Mar 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K45/06, A61K9/0053, A61P, A61P35/00